341 related articles for article (PubMed ID: 8042236)
21. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease.
Marcellin P; Samuel D; Areias J; Loriot MA; Arulnaden JL; Gigou M; David MF; Bismuth A; Reynes M; Bréchot C
Hepatology; 1994 Jan; 19(1):6-12. PubMed ID: 8276368
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
[TBL] [Abstract][Full Text] [Related]
23. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.
Perrillo RP; Wright T; Rakela J; Levy G; Schiff E; Gish R; Martin P; Dienstag J; Adams P; Dickson R; Anschuetz G; Bell S; Condreay L; Brown N;
Hepatology; 2001 Feb; 33(2):424-32. PubMed ID: 11172345
[TBL] [Abstract][Full Text] [Related]
24. [De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates].
Rambusch EG; Nashan B; Tillmann HL; Böker KH; Schlitt HJ; Maschek H; Raab R; Manns MP
Z Gastroenterol; 1998 Dec; 36(12):1027-35. PubMed ID: 10025054
[TBL] [Abstract][Full Text] [Related]
25. Role of liver transplantation in patients with hepatitis B infection.
Holt CD; Millis JM; Busuttil RW
Clin Transplant; 1995 Jun; 9(3 Pt 2):269-76. PubMed ID: 7670175
[TBL] [Abstract][Full Text] [Related]
26. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
[TBL] [Abstract][Full Text] [Related]
27. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
Caccamo L; Romeo R; Rossi G; Maggioni M; Radice F; Lunghi G; Colombo M; Fassati LR
Transpl Int; 2005 Feb; 18(2):186-92. PubMed ID: 15691271
[TBL] [Abstract][Full Text] [Related]
28. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
Abdelmalek MF; Pasha TM; Zein NN; Persing DH; Wiesner RH; Douglas DD
Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824
[TBL] [Abstract][Full Text] [Related]
29. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
[TBL] [Abstract][Full Text] [Related]
30. Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression.
Toniutto P; Minisini R; Fabris C; De Feo T; Marangoni F; Burlone M; Avellini C; Bitetto D; Fornasiere E; Fumolo E; Baccarani U; Pirisi M
Clin Transplant; 2009; 23(2):184-90. PubMed ID: 19210526
[TBL] [Abstract][Full Text] [Related]
31. Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations.
Demetris AJ; Todo S; Van Thiel DH; Fung JJ; Iwaki Y; Sysyn G; Ming W; Trager J; Starzl TE
Am J Pathol; 1990 Sep; 137(3):667-76. PubMed ID: 2399936
[TBL] [Abstract][Full Text] [Related]
32. Long-term prevention of recurrent hepatitis B virus after liver transplantation.
Ilan Y; Eid A; Tur-Kaspa R
Isr J Med Sci; 1995 Aug; 31(8):469-73. PubMed ID: 7635695
[TBL] [Abstract][Full Text] [Related]
33. [Experiences with liver transplantation in hepatitis B antigen positive liver cirrhosis].
Steininger R; Mühlbacher F; Längle F; Gnant M; Sautner T; Götzinger P; Walgram M; Penner E; Radaszkiewicz T
Wien Klin Wochenschr; 1991; 103(19):573-6. PubMed ID: 1759457
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of the hepatitis B virus-DNA concentration in patients after orthotopic liver transplantation.
Zöllner B; Polywka S; Feucht HH; Martens H; Iske L; Oehler G; Laufs R
Hepatogastroenterology; 1994 Oct; 41(5):424-6. PubMed ID: 7851849
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation.
Angus PW; Locarnini SA; McCaughan GW; Jones RM; McMillan JS; Bowden DS
Hepatology; 1995 Jan; 21(1):14-8. PubMed ID: 7806147
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report.
Sinclair SB; Greig PD; Blendis LM; Abecassis M; Roberts EA; Phillips MJ; Cameron R; Levy GA
J Clin Invest; 1989 Oct; 84(4):1063-9. PubMed ID: 2794044
[TBL] [Abstract][Full Text] [Related]
37. Impact of human leukocyte antigen matching on hepatitis B virus recurrence after liver transplantation.
Zhao H; Hu JH; Zhou L; Xu X; Wu J; Meng XQ; Fan J; Ma WH
Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):139-43. PubMed ID: 20382583
[TBL] [Abstract][Full Text] [Related]
38. Transplantation of a hepatitis B surface antigen-positive donor liver into a hepatitis B virus-negative recipient.
González-Peralta RP; Andres JM; Tung FY; Fang JW; Brunson ME; Davis GL; Lau JY
Transplantation; 1994 Jul; 58(1):114-6. PubMed ID: 8036699
[TBL] [Abstract][Full Text] [Related]
39. Pre-core mutants of hepatitis B virus in patients receiving immunosuppressive treatment after orthotopic liver transplantation.
Protzer U; Goergen B; Hopf U; Neuhaus P; König V; Meyer zum Büschenfelde KH; Gerken G
J Med Virol; 1996 Oct; 50(2):135-44. PubMed ID: 8915879
[TBL] [Abstract][Full Text] [Related]
40. Acute pancreatitis following liver transplantation.
Camargo CA; Greig PD; Levy GA; Clavien PA
J Am Coll Surg; 1995 Sep; 181(3):249-56. PubMed ID: 7545514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
